Litigation Details for SUCAMPO GMBH v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2020)
✉ Email this page to a colleague
SUCAMPO GMBH v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2020)
Docket | ⤷ Sign Up | Date Filed | 2020-01-28 |
Court | District Court, D. New Jersey | Date Terminated | 2020-11-13 |
Cause | 15:1126 Patent Infringement | Assigned To | Freda L. Wolfson |
Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
Patents | 7,795,312; 8,026,393; 8,338,639; 8,748,481; 8,779,187 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in SUCAMPO GMBH v. ZYDUS PHARMACEUTICALS (USA) INC.
Details for SUCAMPO GMBH v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2020-01-27 | 1 | Complaint | Sucampo AG) owns United States Patent No. 7,795,312 (“the ’312 patent”) titled, “Method for Treating …action for infringement of United States Patent Nos. 7,795,312, 8,026,393, 8,338,639, 8,779,187, and 8,748,481…481 patents, or any later expiration of any patent term extension or exclusivity for these patents to …8,748,481 (collectively, “the patents-in-suit”). This action arises under the Patent Laws of the United States…The ’312 patent was duly and legally issued on September 14, 2010. A copy of the ’312 patent is attached | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |